| 000 | 01065nam a2200157Ia 4500 | ||
|---|---|---|---|
| 008 | 140223b2004 xxu||||| |||| 00| 0 eng d | ||
| 020 |
_a9780824753207 _c0.00 |
||
| 082 |
_a615.9 _bMIC |
||
| 245 | _aMicrobial Contamination Control in Parenteral Manufacturing | ||
| 260 |
_aNew York _bMarcel Dekker, Inc. _c2004 |
||
| 300 | _a721p | ||
| 500 | _aThis reference surveys emerging trends, concepts, and procedures used in the characterization and control of contaminants; the sterile production of traditional drugs and biologics; the design, construction, and validation of new parenteral facilities; and the monitoring of clean environments-vividly illustrating the routes by which products, processes, and manufacturing settings become contaminated through contact with the air, water, raw materials, and the actions of personnel, as well as the current methods necessary to successfully preclude contamination. | ||
| 700 |
_aWilliams, Kevin L. _eEditor _9108897 |
||
| 942 |
_2ddc _cLB |
||
| 995 |
_aPharmacy Reference _eP0001530 _j616.9 _yP0001530 |
||
| 999 |
_c15842 _d15842 |
||